Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms WWL0245 |
Target |
Action degraders |
Mechanism BRD4 degraders(Bromodomain-containing protein 4 degraders), Epigenetic drug |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC45H51N11O8 |
InChIKeyAORZPRLVKUMTOJ-XGDNGBMYSA-N |
CAS Registry2869057-11-2 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Prostatic Cancer | Preclinical | China | 01 Jan 2022 |





